Cargando…
Amplifying STING Activation by Cyclic Dinucleotide-Manganese Particles for Local and Systemic Cancer Metalloimmunotherapy
Nutritional metal ions play critical roles in many important immune processes. Hence, effective modulation of metal ions may open up new forms of immunotherapy, termed as metalloimmunotherapy. Here, we demonstrate a prototype of cancer metalloimmunotherapy using cyclic dinucleotide (CDN) stimulator...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8595610/ https://www.ncbi.nlm.nih.gov/pubmed/34594005 http://dx.doi.org/10.1038/s41565-021-00962-9 |
_version_ | 1784600218156662784 |
---|---|
author | Sun, Xiaoqi Zhang, Yu Li, Jiaqian Park, Kyung Soo Han, Kai Zhou, Xingwu Xu, Yao Nam, Jutaek Xu, Jin Shi, Xiaoyue Wei, Lei Lei, Yu Leo Moon, James J. |
author_facet | Sun, Xiaoqi Zhang, Yu Li, Jiaqian Park, Kyung Soo Han, Kai Zhou, Xingwu Xu, Yao Nam, Jutaek Xu, Jin Shi, Xiaoyue Wei, Lei Lei, Yu Leo Moon, James J. |
author_sort | Sun, Xiaoqi |
collection | PubMed |
description | Nutritional metal ions play critical roles in many important immune processes. Hence, effective modulation of metal ions may open up new forms of immunotherapy, termed as metalloimmunotherapy. Here, we demonstrate a prototype of cancer metalloimmunotherapy using cyclic dinucleotide (CDN) stimulator of interferon genes (STING) agonists and Mn(2+). We screened various metal ions and discovered specific metal ions augmented STING agonist activity, wherein Mn(2+) promoted a 12- to 77-fold potentiation effect across the prevalent human STING haplotypes. Notably, Mn(2+) coordinated with CDN STING agonists to self-assemble into a nanoparticle (CDN-Mn(2+) particle, CMP) that effectively delivered STING agonists to immune cells. CMP administered either by local intratumoral or systemic intravenous injection initiated robust anti-tumor immunity, achieving remarkable therapeutic efficacy with minute doses of STING agonists in multiple murine tumor models. Overall, CMP offers a new platform for local and systemic cancer treatments, and this work underscores the great potential of coordination nanomedicine for metalloimmunotherapy. |
format | Online Article Text |
id | pubmed-8595610 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
record_format | MEDLINE/PubMed |
spelling | pubmed-85956102022-03-30 Amplifying STING Activation by Cyclic Dinucleotide-Manganese Particles for Local and Systemic Cancer Metalloimmunotherapy Sun, Xiaoqi Zhang, Yu Li, Jiaqian Park, Kyung Soo Han, Kai Zhou, Xingwu Xu, Yao Nam, Jutaek Xu, Jin Shi, Xiaoyue Wei, Lei Lei, Yu Leo Moon, James J. Nat Nanotechnol Article Nutritional metal ions play critical roles in many important immune processes. Hence, effective modulation of metal ions may open up new forms of immunotherapy, termed as metalloimmunotherapy. Here, we demonstrate a prototype of cancer metalloimmunotherapy using cyclic dinucleotide (CDN) stimulator of interferon genes (STING) agonists and Mn(2+). We screened various metal ions and discovered specific metal ions augmented STING agonist activity, wherein Mn(2+) promoted a 12- to 77-fold potentiation effect across the prevalent human STING haplotypes. Notably, Mn(2+) coordinated with CDN STING agonists to self-assemble into a nanoparticle (CDN-Mn(2+) particle, CMP) that effectively delivered STING agonists to immune cells. CMP administered either by local intratumoral or systemic intravenous injection initiated robust anti-tumor immunity, achieving remarkable therapeutic efficacy with minute doses of STING agonists in multiple murine tumor models. Overall, CMP offers a new platform for local and systemic cancer treatments, and this work underscores the great potential of coordination nanomedicine for metalloimmunotherapy. 2021-09-30 2021-11 /pmc/articles/PMC8595610/ /pubmed/34594005 http://dx.doi.org/10.1038/s41565-021-00962-9 Text en Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use: https://www.springernature.com/gp/open-research/policies/accepted-manuscript-terms |
spellingShingle | Article Sun, Xiaoqi Zhang, Yu Li, Jiaqian Park, Kyung Soo Han, Kai Zhou, Xingwu Xu, Yao Nam, Jutaek Xu, Jin Shi, Xiaoyue Wei, Lei Lei, Yu Leo Moon, James J. Amplifying STING Activation by Cyclic Dinucleotide-Manganese Particles for Local and Systemic Cancer Metalloimmunotherapy |
title | Amplifying STING Activation by Cyclic Dinucleotide-Manganese Particles for Local and Systemic Cancer Metalloimmunotherapy |
title_full | Amplifying STING Activation by Cyclic Dinucleotide-Manganese Particles for Local and Systemic Cancer Metalloimmunotherapy |
title_fullStr | Amplifying STING Activation by Cyclic Dinucleotide-Manganese Particles for Local and Systemic Cancer Metalloimmunotherapy |
title_full_unstemmed | Amplifying STING Activation by Cyclic Dinucleotide-Manganese Particles for Local and Systemic Cancer Metalloimmunotherapy |
title_short | Amplifying STING Activation by Cyclic Dinucleotide-Manganese Particles for Local and Systemic Cancer Metalloimmunotherapy |
title_sort | amplifying sting activation by cyclic dinucleotide-manganese particles for local and systemic cancer metalloimmunotherapy |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8595610/ https://www.ncbi.nlm.nih.gov/pubmed/34594005 http://dx.doi.org/10.1038/s41565-021-00962-9 |
work_keys_str_mv | AT sunxiaoqi amplifyingstingactivationbycyclicdinucleotidemanganeseparticlesforlocalandsystemiccancermetalloimmunotherapy AT zhangyu amplifyingstingactivationbycyclicdinucleotidemanganeseparticlesforlocalandsystemiccancermetalloimmunotherapy AT lijiaqian amplifyingstingactivationbycyclicdinucleotidemanganeseparticlesforlocalandsystemiccancermetalloimmunotherapy AT parkkyungsoo amplifyingstingactivationbycyclicdinucleotidemanganeseparticlesforlocalandsystemiccancermetalloimmunotherapy AT hankai amplifyingstingactivationbycyclicdinucleotidemanganeseparticlesforlocalandsystemiccancermetalloimmunotherapy AT zhouxingwu amplifyingstingactivationbycyclicdinucleotidemanganeseparticlesforlocalandsystemiccancermetalloimmunotherapy AT xuyao amplifyingstingactivationbycyclicdinucleotidemanganeseparticlesforlocalandsystemiccancermetalloimmunotherapy AT namjutaek amplifyingstingactivationbycyclicdinucleotidemanganeseparticlesforlocalandsystemiccancermetalloimmunotherapy AT xujin amplifyingstingactivationbycyclicdinucleotidemanganeseparticlesforlocalandsystemiccancermetalloimmunotherapy AT shixiaoyue amplifyingstingactivationbycyclicdinucleotidemanganeseparticlesforlocalandsystemiccancermetalloimmunotherapy AT weilei amplifyingstingactivationbycyclicdinucleotidemanganeseparticlesforlocalandsystemiccancermetalloimmunotherapy AT leiyuleo amplifyingstingactivationbycyclicdinucleotidemanganeseparticlesforlocalandsystemiccancermetalloimmunotherapy AT moonjamesj amplifyingstingactivationbycyclicdinucleotidemanganeseparticlesforlocalandsystemiccancermetalloimmunotherapy |